Ad
related to: bluebird bio news
Search results
If You Invested $10,000 in Bluebird Bio In 2021, This Is How Much You Would Have Today
Motley Fool via Yahoo Finance· 5 months agoIt has been just over two years since Bluebird Bio (NASDAQ: BLUE) split into two separate companies....
Is Bluebird Bio Stock a Buy Now?
Motley Fool via Yahoo Finance· 3 months agoPenny stocks -- companies whose shares are trading for $5 or less -- look cheap for a reason: They have encountered severe issues, and the market has...
2 Red Flags for Bluebird Bio Stock
Motley Fool via Yahoo Finance· 5 months agoThe past couple of years have been eventful for Bluebird Bio (NASDAQ: BLUE). In 2022, the gene-editing specialist earned approval for two therapies in...
Better Risky Investment: Bluebird Bio vs. Shiba Inu
Motley Fool via Yahoo Finance· 5 months agoWhat does a gene therapy biotech like Bluebird Bio (NASDAQ: BLUE) have to do with a cryptocurrency like Shiba Inu (CRYPTO: SHIB), one of the hottest meme...
Should You Invest in Bluebird Bio Right Now?
Motley Fool via Yahoo Finance· 5 months agoBenjamin Graham and Warren Buffett may urge investors to buy when there's blood on the streets, but even the best advice has its limitations. In the case...
FDA Committee Endorses bluebird's (BLUE) Thalassemia Therapy
Zacks via Yahoo Finance· 2 years agoAn FDA advisory committee favors approval for bluebird bio's (BLUE) beti-cel to treat...
More Likely to 5x First: Bluebird Bio vs. CRISPR Therapeutics
Motley Fool· 9 months agoGene editing is a relatively new technology that allows scientists to modify an organism's DNA. Two...
bluebird's (BLUE) Gene Therapy Gets FDA Nod for Beta-Thalassemia
Zacks via Yahoo Finance· 2 years agobluebird bio BLUE recently announced that the FDA has approved Zynteglo (betibeglogene autotemcel),...
These 2 Stocks Could Be About to Soar: Are They Buys?
Motley Fool· 6 months agoShares of relatively small biotech companies often soar when they get positive news from regulators,...
Why Bluebird Bio Stock Crushed the Market Today
Motley Fool· 1 year agoBluebird Bio (NASDAQ: BLUE) stock got off to a roaring start on Monday, trouncing the S&P 500 index with a nearly 8% gain. The market was cheered by a...
